List of articles with "Kedrion Biopharma"

Kedrion at IPIC 2025

Kedrion at IPIC 2025

USA Prague Kedrion Biopharma IPIC 2025 Secondary Immunodeficiencies
Kedrion at IPIC 2025

Kedrion at IPIC 2025

Italy Kedrion Biopharma Castelvecchio Pascoli Immunodeficiencies IPIC 2025
Kedrion at IPIC 2025

Kedrion at IPIC 2025

Czech Republic Prague Kedrion Biopharma IPIC 2025 Secondary Immunodeficiencies
Kedrion at IPIC 2025

Kedrion at IPIC 2025

USA Prague Kedrion Biopharma Immunodeficiencies IPIC 2025
YIMMUGO® Launches in U.S.

YIMMUGO® Launches in U.S.

United States Fort Lee Primary Immunodeficiency Kedrion Biopharma YIMMUGO
Kedrion's QIVIGY FDA Approval

Kedrion's QIVIGY FDA Approval

United States FDA Approval Fort Lee Kedrion Biopharma QIVIGY
Kedrion's COAGADEX® ODD

Kedrion's COAGADEX® ODD

USA Fort Lee, NJ Kedrion Biopharma COAGADEX aFXD
Kedrion's Growth & Change

Kedrion's Growth & Change

Italy biopharmaceuticals Kedrion Biopharma plasma-derived therapies Castelvecchio Pascoli
Ryplazim Distribution Expansion

Ryplazim Distribution Expansion

United States Fort Lee, NJ Kedrion Biopharma Ryplazim PLGD-1

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.